Modulation of glycine receptor function: A novel approach for therapeutic intervention at inhibitory synapses?

Trends in Pharmacological Sciences

Volumn 23, Issue 11, 2002, Pages 519-527

  Laube, Bodo ^a   Maksay, Gábor ^b   Schemm, Rudolf ^a   Betz, Heinrich ^a  

^a MAX PLANCK INSTITUTE FOR BRAIN RESEARCH   (Germany)

^b CHEMICAL RESEARCH CENTER   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYQUINOLINE 3 CARBOXYLIC ACID; 4 QUINOLINOL; ALANINE; ALCOHOL; ANDROSTERONE; ANESTHETIC AGENT; BETA ALANINE; BETA AMINO ACID; CHLORIDE CHANNEL; DIHYDROPYRIDINE; ENFLURANE; GLYCINE; GLYCINE RECEPTOR; GLYCINE RECEPTOR AGONIST; GLYCINE RECEPTOR ANTAGONIST; HALOTHANE; ION CHANNEL; ISOFLURANE; ISOPROTEIN; METHOXYFLURANE; MINAXOLONE; PICROTOXININ; PRASTERONE; PREGNENOLONE; PROPOFOL; QUINOLINIC ACID DERIVATIVE; SERINE; SEVOFLURANE; STEROID; STRYCHNINE; TAURINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALLOSTERISM; CENTRAL NERVOUS SYSTEM; DRUG BINDING; DRUG MECHANISM; DRUG POTENTIATION; MAMMAL; MOLECULAR MODEL; PHYLOGENETIC TREE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SYNAPTIC TRANSMISSION;

ANIMALS; HUMANS; MODELS, BIOLOGICAL; MOLECULAR CONFORMATION; RECEPTORS, GLYCINE; SYNAPTIC TRANSMISSION;

EID: 0036842245     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(02)02138-7     Document Type: Review

References (78)

1. Barnard E. Receptor classes and the transmitter-gated ion channels. Trends Biochem. Sci. 17:1992;368-374.
2. Aprison M.H. The discovery of the neurotransmitter role of glycine. Ottersen O.P., Storm-Mathiesen J., Glycine Neurotransmission. 1990;1-23 John Wiley and Sons.
3. Floeter M.K., Hallett M. Glycine receptors: a startling connection. Nat. Genet. 5:1993;319-320.
4. 3H]strychnine. J. Neurosci. 1:1981;532-547.
5. Malosio M.L., et al. Widespread expression of glycine receptor subunit mRNAs in the adult and developing rat brain. EMBO J. 10:1991;2401-2409.
6. Reichling D.B., et al. Mechanisms of GABA and glycine depolarization-induced calcium transients in rat dorsal horn neurons. J. Physiol. (Lond.). 476:1994;411-421.
7. Kirsch J., Betz H. Glycine-receptor activation is required for receptor clustering in spinal neurons. Nature. 392:1998;717-720.
8. - co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation. Nature. 397:1999;251-255.
9. Singer J.H., et al. Development of glycinergic synaptic transmission to rat brain stem motoneurons. J. Neurophysiol. 80:1998;2608-2620.
10. Takahashi T., et al. Functional correlation of fetal and adult forms of glycine receptors with developmental changes in inhibitory synaptic receptor channels. Neuron. 9:1992;1155-1161.
11. Langosch D., et al. Conserved quaternary structure of ligand gated ion channels: the postsynaptic glycine receptor is a pentamer. Proc. Natl. Acad. Sci. U. S. A. 85:1988;7394-7398.
12. Hoch W., et al. Primary cultures of mouse spinal cord express the neonatal isoform of the inhibitory glycine receptor. Neuron. 3:1989;339-348.
13. Harvey R.J., Betz H. Structure, diversity, pharmacology and pathology of glycine receptor chloride channels. Endo M., et al. Handbook of Experimental Pharmacology. 147:2000;479-497 Springer Verlag.
14. Schmieden V., Betz H. Pharmacology of the inhibitory glycine receptor: agonist and antagonist actions of amino acids and piperidine carboxylic acid compounds. Mol. Pharmacol. 48:1995;919-927.
15. De Saint Jan D., et al. Activation of human α1 and α2 homomeric glycine receptors by taurine and GABA. J. Physiol. (Lond.). 535:2001;741-755.
16. Shan Q., et al. Ivermectin, an unconventional agonist of the glycine receptor chloride channel. J. Biol. Chem. 276:2001;12556-12564.
17. Becker C-M. Convulsants acting at the inhibitory glycine receptor. Herken H., Hucho F., Handbook of Experimental Pharmacology. 1992;539-575 Springer Verlag.
18. Young A.B., Snyder S.H. Strychnine binding associated with glycine receptors of the central nervous system. Proc. Natl. Acad. Sci. U. S. A. 70:1973;2832-2836.
19. Schmieden V., et al. Novel antagonists of the inhibitory glycine receptor derived from quinolinic acid compounds. Mol. Pharmacol. 50:1996;1200-1206.
20. Pribilla I., et al. The atypical M2 segment of the β subunit confers picrotoxinin resistance to inhibitory glycine receptor channels. EMBO J. 11:1992;4305-4311.
21. Bormann J., et al. Residues within transmembrane segment M2 determine chloride conductance of glycine receptor homo- and hetero-oligomers. EMBO J. 12:1993;3729-3737.
22. Lynch J., et al. Mutations affecting the glycine receptor agonist transduction mechanism convert the competitive antagonist, picrotoxin, into an allosteric potentiator. J. Biol. Chem. 270:1995;13799-13806.
23. Rundström N., et al. Cyanotriphenylborate: subtype-specific blocker of glycine receptor chloride channels. Proc. Natl. Acad. Sci. U. S. A. 91:1994;8950-8954.
24. A and glycine receptor function. Neurochem. Int. 35:1999;115-123.
25. Mascia M.P., et al. Enhancement of homomeric glycine receptor function by long-chain alcohols and anaesthetics. Br. J. Pharmacol. 119:1996;1331-1336.
26. Hales T.G., Lambert J.J. The actions of propofol on inhibitory amino acid receptors of bovine adrenomedullary chromaffin cells and rodent central neurones. Br. J. Pharmacol. 104:1991;619-628.
27. Mascia M.P., et al. A single amino acid determines differences in ethanol actions on strychnine-sensitive glycine receptors. Mol. Pharmacol. 50:1996;402-406.
28. Downie D.L., et al. Effects of inhalational general anaesthetics on native glycine receptors in rat medullary neurones and recombinant glycine receptors in Xenopus oocytes. Br. J. Pharmacol. 118:1996;493-502.
29. Wu F.S., et al. Inverse modulation of γ-aminobutyric acid- and glycine-induced currents by progesterone. Mol. Pharmacol. 37:1990;597-602.
30. Maksay G., et al. Subunit-specific modulation of glycine receptors by neurosteroids. Neuropharmacology. 41:2001;369-376.
31. A receptor. Baulieu E.E., et al. Neurosteroids. 1999;125-142 Humana Press.
32. Chesnoy-Marchais D., Cathala L. Modulation of glycine responses by dihydropyridines and verapamil in rat spinal neurons. Eur. J. Neurosci. 13:2001;2195-2204.
33. 3 receptor antagonists. Drugs. 53:1997;20-39.
34. Chesnoy-Marchais D. Potentiation of chloride responses to glycine by three 5-HT3 antagonists in rat spinal neurones. Br. J. Pharmacol. 118:1996;2115-2125.
35. 3 serotonin receptor ligands. Neuropharmacology. 37:1998;1633-1641.
36. Maksay G., et al. Selective blocking effects of tropisetron and atropine on recombinant glycine receptors. J. Neurochem. 73:1999;802-806.
37. Supplisson S., Chesnoy-Marchais D. Glycine receptor β subunits play a critical role in potentiation of glycine responses by ICS-205,930. Mol. Pharmacol. 58:2000;763-770.
38. 2+ from brain tissue during activity. Nature. 308:1984;734-738.
39. Smart T.G., et al. Modulation of inhibitory and excitatory amino acid receptor ion channels by zinc. Prog. Neurobiol. 42:1994;393-441.
40. 2+. Mol. Pharmacol. 46:1994;1156-1159.
41. Laube B., et al. Modulation by zinc ions of native rat and recombinant human inhibitory glycine receptors. J. Physiol. (Lond.). 483:1995;613-619.
42. Lynch J.W., et al. Zinc potentiation of the glycine receptor chloride channel is mediated by allosteric pathways. J. Neurochem. 71:1998;2159-2168.
43. 2+ modulation of recombinant human inhibitory glycine receptors. J. Physiol. (Lond.). 522:2000;215-230.
44. Schmieden V., et al. Mutation of glycine receptor subunit creates β-alanine receptor responsive to GABA. Science. 262:1993;256-258.
45. Kuhse J., et al. A single amino acid exchange alters the pharmacology of neonatal rat glycine receptor subunit. Neuron. 5:1990;867-873.
46. Schmieden V., et al. A novel domain of the inhibitory glycine receptor determining antagonist efficacies: further evidence for partial agonism resulting from self-inhibition. Mol. Pharmacol. 56:1999;464-472.
47. Vandenberg R.J., et al. Antagonism of ligand-gated ion channel receptors: two domains of the glycine receptor a subunit form the strychnine-binding site. Proc. Natl. Acad. Sci. U. S. A. 89:1992;1765-1769.
48. Vandenberg R.J., et al. Distinct agonist- and antagonist-binding sites on the glycine receptor. Neuron. 9:1992;491-496.
49. Breitinger H.G., Becker C.M. The inhibitory glycine receptor: prospects for a therapeutic orphan? Curr. Pharm. Des. 4:1998;315-334.
50. Rajendra S., et al. The glycine receptor. Pharmacol. Ther. 73:1997;121-146.
51. Laube B., et al. Hyperekplexia mutations of the glycine receptor unmask the inhibitory subsite for β-amino-acids. Neuroreport. 6:1995;897-900.
52. Rajendra S., et al. Mutation of an arginine residue in the human glycine receptor transforms β-alanine and taurine from agonists into competitive antagonists. Neuron. 14:1995;169-175.
53. Schofield P.R., et al. Molecular and genetic insights into ligand binding and signal transduction at the inhibitory glycine receptor. Cold Spring Harb. Symp. Quant. Biol. 61:1996;333-342.
54. Moorhouse A.J., et al. The startle disease mutation Q266H in the second transmembrane domain of the human glycine receptor impairs channel gating. Mol. Pharmacol. 55:1999;386-395.
55. Rajendra S., et al. Startle disease mutations reduce the agonist sensitivity of the human inhibitory glycine receptor. J. Biol. Chem. 269:1994;18739-18742.
56. Steinbach J.H., et al. Subunit-specific action of an anticonvulsant thiobutyrolactone on recombinant glycine receptors involves a residue in the M2 membrane-spanning region. Mol. Pharmacol. 58:2000;11-17.
57. Ye Q., et al. Enhancement of glycine receptor function by ethanol is inversely correlated with molecular volume at position S267. J. Biol. Chem. 273:1998;3314-3319.
58. Beckstead M.J., et al. Antagonism of inhalant and volatile anesthetic enhancement of glycine receptor function. J. Biol. Chem. 276:2001;24959-24964.
59. Mascia M.P., et al. Specific binding sites for alcohols and anesthetics on ligand-gated ion channels. Proc. Natl. Acad. Sci. U. S. A. 97:2000;9305-9310.
60. Mihic S.J., et al. Sites of alcohol and volatile anaesthetic action on GABA and glycine receptors. Nature. 389:1997;385-389.
61. A and glycine receptors expressed in Xenopus laevis oocytes: a comparative study. Br. J. Pharmacol. 122:1997;1707-1719.
62. Harvey R., et al. Identification of an inhibitory zinc binding site on the human glycine receptor α subunit. J. Physiol. 520:1999;53-64.
63. Devillers-Thiery A., et al. Functional architecture of the nicotinic acetylcholine receptor: a prototype of ligand-gated ion channels. J. Membr. Biol. 136:1993;97-112.
64. Brejc K., et al. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature. 411:2001;269-276.
65. Vafa B., et al. Identification of a new ligand binding domain in the α1 subunit of the inhibitory glycine receptor. J. Neurochem. 73:1999;2158-2166.
66. Han N-L., et al. Characterization of a glycine receptor domain that controls the binding and gating mechanisms of the amino acid agonist, taurine. J. Neurochem. 79:2001;636-647.
67. Unwin N. Acetylcholine receptor channel imaged in the open state. Nature. 373:1995;37-43.
68. Takahama K., et al. Inhibition of glycine currents by dextromethorphan in neurones dissociated from the guinea-pig nucleus tractus solitarii. Br. J. Pharmacol. 120:1997;690-694.
69. Hosie A., et al. Actions of 3-[2′-phosphonomethyl[1,1′-biphenyl]-3-yl]alanine (PMBA) on cloned glycine receptors. Br. J. Pharmacol. 126:1999;1230-1236.
70. Machu T. Colchicine competitively antagonizes glycine receptors expressed in Xenopus oocytes. Neuropharmacology. 37:1998;391-396.
71. 3H]strychnine binding sites in rat spinal cord and brain stem. Eur. J. Pharmacol. 318:1996;201-204.
72. - currents of acutely dissociated rat hippocampal neurons. Eur. J. Pharmacol. 367:1999;125-130.
73. Huang R.Q., Dillon G.H. Direct inhibition of glycine receptors by genistein, a tyrosine kinase inhibitor. Neuropharmacology. 39:2000;2195-2204.
74. Kumamoto E., Murata Y. Action of furosemide on GABA and glycine currents in rat septal cholinergic neurons in culture. Brain Res. 776:1997;246-249.
75. A and glycine receptor channels. Eur. J. Pharmacol. 415:2001;135-140.
76. Machu T.K., et al. Selective actions of a detergent on ligand-gated ion channels expressed in Xenopus oocytes. J. Pharmacol. Exp. Ther. 284:1998;32-36.
77. A and glycine receptors by chlormethiazole. Eur. J. Pharmacol. 210:1992;239-246.
78. Wittekindt B., et al. Point mutations identify the glutamate binding pocket of the N-methyl-D-aspartate receptor as major site of conantokin-G inhibition. Neuropharmacology. 41:2001;753-761.